| 发明名称 |
METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS |
| 摘要 |
<p>The present invention relates to a method tor evaluating patterns to help-optimizing the treatment of chronic myeloid leukemia (CML) in a human patient population. Specifically, present invention relates to SHP1 and/or SHP2 as a biomarker for CML patients.</p> |
| 申请公布号 |
KR20110095878(A) |
申请公布日期 |
2011.08.25 |
| 申请号 |
KR20117012760 |
申请日期 |
2009.11.05 |
| 申请人 |
NOVARTIS AG |
发明人 |
ESPOSITO NICOLA;IZZO BARBARA;KALEBIC THEA;PANE FABRIZIO;QUARANTELLI FABRIZIO |
| 分类号 |
C12Q1/42;C12N9/16;C12Q1/68 |
主分类号 |
C12Q1/42 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
